Jordan P. Colorectal Cancer Subtypes - The Current Portrait. Adv Exp Med Biol. 2018;1110:1-6 pubmed publisher
Matos P, Jordan P. Targeting Colon Cancers with Mutated BRAF and Microsatellite Instability. Adv Exp Med Biol. 2018;1110:7-21 pubmed publisher
..As cytotoxic lymphocytes are already part of the tumour environment, their activation by immune checkpoint therapy approaches is highly promising. ..
Matos P, Jordan P. Beyond COX-inhibition: 'side-effects' of ibuprofen on neoplastic development and progression. Curr Pharm Des. 2015;21:2978-82 pubmed
Henriques A, Barros P, Moyer M, Matos P, Jordan P. Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells. Cancer Lett. 2015;369:368-75 pubmed publisher
Matos L, Gonçalves V, Pinto E, Laranjeira F, Prata M, Jordan P, et al
. Functional analysis of splicing mutations in the IDS gene and the use of antisense oligonucleotides to exploit an alternative therapy for MPS II. Biochim Biophys Acta. 2015;1852:2712-21 pubmed publisher
Matos L, Canals I, Dridi L, Choi Y, Prata M, Jordan P, et al
. Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations. Orphanet J Rare Dis. 2014;9:180 pubmed publisher
..We have assayed two therapeutic strategies for different splicing mutations with promising results for the future applications. ..
Matos P, Gonçalves V, Jordan P. Targeting the serrated pathway of colorectal cancer with mutation in BRAF. Biochim Biophys Acta. 2016;1866:51-63 pubmed publisher
..Subsequently, available therapeutic approaches for targeting these molecular characteristics are presented and critically discussed. ..
Gonçalves V, Pereira J, Jordan P. Signaling Pathways Driving Aberrant Splicing in Cancer Cells. Genes (Basel). 2017;9: pubmed publisher
Pereira J, Awatade N, Loureiro C, Matos P, Amaral M, Jordan P. The third dimension: new developments in cell culture models for colorectal research. Cell Mol Life Sci. 2016;73:3971-89 pubmed publisher